To determine whether long-term CPT treatment could sustain high circulating levels of GDF15 and thereby alleviates obesity in mice, we performed longitudinal study in which both DIO mice and ob/ob mice orally received 1 mg kg−1 day−1 of CPT for 30 days. This evidence concerns the gene GDF15 and obesity disorder.